Current approaches in dendritic cell generation and future implications for cancer immunotherapy Sandra TuyaertsJoeri L. AertsAude Bonehill Review 15 May 2007 Pages: 1513 - 1537
In situ expression of IFN-γ-inducible T cell α chemoattractant in breast cancer mounts an enhanced specific anti-tumor immunity which leads to tumor regression Yiwei ChuXiuli YangSidong Xiong Original Article 14 February 2007 Pages: 1539 - 1549
The effect of dexamethasone on polyclonal T cell activation and redirected target cell lysis as induced by a CD19/CD3-bispecific single-chain antibody construct Christian BrandlCornelia HaasRobert Hofmeister Original Article 20 February 2007 Pages: 1551 - 1563
A HLA-DQ5 restricted Melan-A/MART-1 epitope presented by melanoma tumor cells to CD4+ T lymphocytes Pierre LarrieuLaure-Hélène OuisseJean-François Fonteneau Original Article 23 February 2007 Pages: 1565 - 1575
Simultaneous ex vivo quantification of antigen-specific CD4+ and CD8+ T cell responses using in vitro transcribed RNA Sebastian KreiterThorsten KonradUgur Sahin Original Article 15 March 2007 Pages: 1577 - 1587
CXC chemokine receptor 4 is expressed in uveal malignant melanoma and correlates with the epithelioid-mixed cell type Stefania ScalaCaterina IeranòGiuseppe Castello Original Article 05 April 2007 Pages: 1589 - 1595
Single administration of low dose cyclophosphamide augments the antitumor effect of dendritic cell vaccine Ji-Yan LiuYang WuYi-Xin Zeng Original Article 18 April 2007 Pages: 1597 - 1604
Eradication of hepatoma and colon cancer in mice with Flt3L gene therapy in combination with 5-FU Sheng HouGeng KouYajun Guo Original Article 15 March 2007 Pages: 1605 - 1613
Generation of robust cytotoxic T lymphocytes against prostate specific antigen by transduction of dendritic cells using protein and recombinant adeno-associated virus Mahendran MahadevanYong LiuPaul L. Hermonat Original Article 14 March 2007 Pages: 1615 - 1624
Interleukin-4 impairs granzyme-mediated cytotoxicity of Simian virus 40 large tumor antigen-specific CTL in BALB/c mice Nikola BaschukOlaf UtermöhlenWolfgang Deppert Original Article 13 April 2007 Pages: 1625 - 1636
Treatment of non-small cell lung cancer patients with the trifunctional monoclonal antibody catumaxomab (anti-EpCAM × anti-CD3): a phase I study Martin SebastianBernward PasslickAlexander Schmittel Original Article 05 April 2007 Pages: 1637 - 1644
Immune restoration in head and neck cancer patients after in vivo COX-2 inhibition Stephan LangSanjay TiwariReinhard Zeidler Original Article 27 March 2007 Pages: 1645 - 1652
GM-CSF-secreting cancer immunotherapies: preclinical analysis of the mechanism of action Andrew D. SimmonsBetty LiKarin Jooss Original Article 05 April 2007 Pages: 1653 - 1665
In situ detection of antigen-specific T cells in cryo-sections using MHC class I tetramers after dendritic cell vaccination of melanoma patients I. J. M. De VriesM. R. BernsenG. J. Adema Short Communication 18 April 2007 Pages: 1667 - 1676
Strategies for immune intervention; from bench to bedside Jan DörrieKatrin BirkholzNiels Schaft Meeting Report 29 March 2007 Pages: 1677 - 1685